Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03188718 · ClinicalTrials.gov registry record · NA
WatchPAT Device Validation Study Compared to Polysomnography
A NA study of Sleep and Sleep Disorder, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT03188718: Completed NA study of Sleep and Sleep Disorder, sponsored by University of Colorado, Denver.
NCT03188718 is a NA study of Sleep and Sleep Disorder that has completed, run by University of Colorado, Denver. The registered enrollment target is 45 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03188718, a NA study of Sleep and Sleep Disorder, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Validation study of a novel sleep Device compared to a traditional sleep study.
Primary Outcome
Compare the results to the subjects clinical sleep study results. The PAHI measures presence of sleep apnea. Scores are counts of respiratory events per hour. A score of more than 2 indicates obstructive sleep apnea. Mild = 2-4.9, Moderate = 5-9.9, Severe = 10 or more.
Conditions Studied
Interventions
- DEVICE WatchPAT Intervention
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
What the finished NCT03188718 record still lists
NCT03188718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which WatchPAT Intervention is the first listed.
NCT03188718 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03188718 about?
NCT03188718 is a clinical study titled "WatchPAT Device Validation Study Compared to Polysomnography". Validation study of a novel sleep Device compared to a traditional sleep study.
What is the current status of trial NCT03188718?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-12-07. Estimated completion is 2019-06-01.
What conditions does trial NCT03188718 study?
This clinical trial studies the following conditions: Sleep, Sleep Disorder, Sleep Apnea Syndromes.
What interventions are being tested in trial NCT03188718?
The interventions under investigation include: WatchPAT Intervention (DEVICE).
Who is sponsoring clinical trial NCT03188718?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03188718 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03188718's enrollment target sits among peer trials
45 109th of 151 higher than 42 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI